K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel targeted therapies for cancers with high unmet medical need, today announced completion of dosing ...

In 2025, despite macroeconomic uncertainty due to the tariff environment, we welcomed Medallion Instrumentation Systems, Quality Engineered Services, Aegis Group, and Lilypad Marine to the Patrick ...

Finally, I wanted to spend a brief moment on our capital allocation strategy, which remains a cornerstone of long-term value creation. In addition to reducing leverage, our free cash flow supports a ...

Share Index broke the 170,000-point barrier for the first time, surging 1,975.2 points to close at 170,005.4. The move represents a 1.18% ...